LAS VEGAS, NV / ACCESSWIRE / February 8, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),…
ANN ARBOR, MI / ACCESSWIRE / February 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…
Sustainability Report 2023 Sustainability Report 2023 HYDERABAD, India, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, a leading global…
A clearer vision for surgical robotics: CMR Surgical announces significant update to Versius CMR Surgical launches vLimeLite * a new…
SweetWater Brewing is now the Official Beer Partner of the Atlanta Track Club SweetWater Brewing Company x Atlanta Track Club…
• Initial clinical data suggest the potential of B-VEC to treat lesions in the eye of DEB patients and additional…
- Award Recognizes Approval of Amicus Therapeutics’ Two-component Therapy for the Treatment of Late-onset Pompe Disease -PRINCETON, N.J., Feb. 08,…
– Both dose levels (2E11 & 6E10) demonstrate potential best-in-class clinical activity in hard-to-treat patients including treatment burden reduction and…
SUNNYVALE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on…
CAMBRIDGE, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new…